Conceptual obstacles to research progress in affective disorders

Psychotherapy and Psychosomatics

Volumn 66, Issue 6, 1997, Pages 283-285

  Fava, Giovanni A ^a,b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLASSIFICATION; EDITORIAL; HUMAN; MOOD DISORDER; PSYCHOTHERAPY; RESEARCH; TREATMENT OUTCOME;

HUMANS; MOOD DISORDERS; PSYCHOTHERAPY; RESEARCH; TREATMENT OUTCOME;

EID: 0031297211     PISSN: 00333190     EISSN: 14230348     Source Type: Journal    
DOI: 10.1159/000289149     Document Type: Article

References (25)

1. Fava GA: The concept of recover)' in affective disorders. Psychother Psychosom 1996:65:2-13.
2. Feinstein AR: Twentieth century paradigms that threaten both scientific and human medicine in the twenty-first century. J Clin Epidemiol 1996;6:615-617.
3. Judd LL: Subsyndromal symptomatic depression. CNS Drugs 1994;1:399-404.
4. van Praag HM: About the centrality of mood lowering in mood disorders. Eur Ncuropsycho-pharmacol 1992:2:393-404.
5. Fava GA, Kellner R: Staging. A neglected dimension in psychiatric classification. Acta Psy-chiat Scand 1993;87:225-230.
6. Kellner R: The development of sensitive scales for research in therapeutics; in Fava M, Rosenbaum JF (eds): Research Design and Methods in Psychiatry. Amsterdam. Elsevier, 1992. pp 213-222.
7. Fava GA: Screening and diagnosis of depression: Are criteria used? Disease Management and Health Outcomes 1997;2:1-7.
8. Marks IM: Psychotherapy and pharmacotherapy in anxiety disorders. Eur Psychiatry 1996; 11 (suppl 4): 185s.
9. Basoglu M: Pharmacological and behavioral treatment of panic disorder. Psychother Psychosom 1992;58:57-59.
10. Fava GA: Do antidepressant and antianxicty drugs increase chronicity in affective disorders? Psychother Psychosom 1994:61:125-131.
11. Baldcssarini RJ: Risks and implications of interrupting maintenance psychotropic drug therapy. Psychother Psychosom 1995;63:137-141.
12. Biondi M: Beyond the brain-mind dichotomy and toward a common organizing principle of pharmacological and psychological treatments. Psychother Psychosom 1995:64:1-8.
13. Fava GA: Holding on: Depression, sensitization by antidepressant drugs, and the prodigal experts. Psychother Psychosom 1995:64:57-61.
14. Sonino N, Fava GA: Serotonin. Cushing’s disease. and depression. Psychother Psychosom 1996:65:63-65.
15. Wcxlcr BE, Nelson JC: The treatment of major depressive disorders. Int J Mental Health 1993: 22:7-41.
16. Gelder MG: Treatment of the neuroses. Int J Ment Health 1992;21:3-42.
17. Pollack MH, Otto MW, Kaspi SP, Hammer-ncss PG, Rosenbaum JF: Cognitive-behavior therapy for treatment-refractory panic disorder. J Clin Psychiatry 1994; 55:200-205.
18. Fava GA, Savron G, Grandi S, Rafanelli C: Cognitive behavioral management of drug resistant major depressive disorder. J Clin Psychiatry 1997;58:278-282.
19. Fava GA, Grandi S, Zielezny M, Cancstrari R. Morphy MA: Cognitive behavioral treatment of residual symptoms in primary major depres-sivedisorder. Am J Psychiatry 1994; 151:1295-1299.
20. Fava GA, Grandi S, Zielezny M, Rafanelli C, Cancstrari R: Four-year outcome for cognitive behavioral treatment of residual symptoms in major depression. Am J Psychiatry 1996:153: 945-947.
21. Bech P: Measurement of psychological distress and well-being. Psychother Psychosom 1990; 54:77-89.
22. Fava GA: The concept of psychosomatic disorder. Psychother Psydchosom 1992;58:1-12.
23. Ryff CD. Singer B: Psychological well-being. Psychother Psychosom 1996; 65:14-23.
24. Thunedborg K. Black CH, Bech P: Beyond the Hamilton depression scores in long-term treatment of manic-melancholic patients. Psychother Psychosom 1995;64:131-146.
25. Fava GA, Rafanelli C, Cazzaro M, Conti S, Grandi S: Well-being therapy. A novel psychotherapeutic approach for residual symptoms of affective disorders. Psychol Med, in press.